Article Per Year (5 Year)
p-Index From 2020 - 2025
3.03
P-Index
This Author published in this journals
All Journal Journal of Islamic Pharmacy JMM (Jurnal Masyarakat Mandiri) SELAPARANG: Jurnal Pengabdian Masyarakat Berkemajuan Pharmacology and Clinical Pharmacy Research AL-ULUM: JURNAL SAINS DAN TEKNOLOGI JURNAL FARMASIMED (JFM) Jurnal Sekretari Universitas Pamulang Jurnal Abdidas Jurnal Kesehatan Tambusai Jurnal Buana Farma Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Journal of Innovation Research and Knowledge International Journal of Health and Pharmaceutical (IJHP) Jurnal Pengabdian Kepada Masyarakat Kalam Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan
Juwita Ramadhani
Farmasi, Universitas Islam Kalimantan Muhammad Arsyad Al Banjari Banjarmasin
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Dentistry Economics, Econometrics & Finance Education Energy Engineering Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Mathematics Medicine & Pharmacology Nursing Public Health Social Sciences Other

Published : 22 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : International Journal of Health and Pharmaceutical (IJHP)

 1 
Qualitative Analysis of COVID-19 Vaccine Reactogenicity in Banjarmasin City, South Kalimantan During the Pandemic Muliyani, Muliyani; Isnani, Nazhipah; Annisa, Rahmi; Ramadhani, Juwita
International Journal of Health and Pharmaceutical (IJHP) Vol. 5 No. 4 (2025): November 2025
Publisher : CV. Inara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51601/ijhp.v5i4.457

Abstract

The World Health Organization (WHO) officially recognized COVID-19 as a pandemic. By March 29, 2020, global cases had reached 634,835 with 33,106 fatalities. In Indonesia, there were 1,528 confirmed infections and 136 deaths. According to Indonesia's Presidential Regulation No. 99 of 2020, the government is expediting the acquisition of COVID-19 vaccines and the vaccination program to combat the pandemic. COVID-19 has spread extensively across nearly all provinces in Indonesia. The government remains committed to gradually delivering safe, high-quality, and effective vaccines. Despite these efforts, many people remain hesitant about vaccination due to concerns over side effects and vaccine safety. This study aims to qualitatively analyze the reactogenicity of COVID-19 vaccines. Using a descriptive observational qualitative design, informants were selected through purposive sampling. Reported side effects include drowsiness, injection site pain, increased appetite, fever around 38-39°C, weakness, recurrence of asthma, chest tightness, cough, and runny nose. The most common reactions observed were fever up to 39°C (18.51%) and vomiting (11.11%).
Co-Authors Andryanto, M. Hasan Anggi Saputri, Mutiara Annida Mujahidah Nurul Azmi Aris Fadillah Budianti, Yulistia Didi Susanto Didi Susanto, Didi Erlianti , Karina Erlianti, Karina Fauzi , Muhammad Fauzi Rahman Fauzi Rahman Feteriyani, Rina Fitriyana, Rahma Hardiana, Hardiana Hasniah Hasniah Jaya, Andi Sempurna Karina Erlianti karina erlianti Karina Erlianti Karina Erlianti Karina Erlianti Kurnia, Ina Lia Mardiana Mardiana, Lia Muhammad Abdi, Muhammad Muhammad Fauzi Muhammad Fauzi Muliyani Muliyani Nabila, Regina Syifa Nazhipah Isnani Normila, Normila Pratama, Rizki R. Rahmi Annisa Rony, Rony Safari, Astina Soemarie, Yulistia Budianti Su'aida, Nily Syahidah, Annisa